Skip to main content

and
  1. No Access

    Article

    Effects of supidimide in schizophrenic inpatients undergoing neuroleptic maintenance therapy with haloperidol

    Forty schizophrenic inpatients, on constant low-dosage maintenance therapy with haloperidol, entered a superimposed, double-blind, placebo-controlled clinical trial with supidimide 2×200 mg per day. The double...

    V. Rapisarda, E. Aguglia, A. Poma in European Journal of Clinical Pharmacology (1982)